MyRocky GLP-1 Weight Loss Review (2026): Generic Semaglutide From $149/Month
MyRocky is the cheapest credible GLP-1 program in Canada and the only major platform serving all ten provinces. Here is what the $99 consult buys and where the catch is.
Reviewed · ExploreTreatments Canada editorial team
About MyRocky
MyRocky is a Canadian telehealth provider that pairs an online clinic with an in-house licensed pharmacy. It is LegitScript certified, has enrolled over 350,000 Canadians, and names its clinical leadership publicly — Dr. George Mankaryous, MD CCFP, and pharmacist-in-charge Mina Rizk, RPh MPharm. Naming the responsible clinicians is not universal in this market, and it matters.
The core offer is generic semaglutide — the same active molecule as Ozempic — from around $149 per month, which undercuts brand-name programs substantially. Canada became the first G7 country to authorize a generic semaglutide, and MyRocky was among the first Canadian platforms to build a program around it.
The structural advantage is the in-house pharmacy. Most Canadian telehealth platforms write a prescription and route it to a third-party pharmacy, which is where refill delays originate. MyRocky dispenses directly, which removes that transfer step entirely — a detail that matters more for a weekly injection than it sounds.
MyRocky also serves all ten provinces, including Quebec and New Brunswick. Quebec is regulated separately through the Collège des médecins du Québec and is excluded by most national platforms, so for Quebec residents this is frequently the only real option.
At a Glance
| Generic semaglutide | From ~$149/month |
|---|---|
| Initial consultation | $99 one-time |
| Brand-name options | Ozempic and Mounjaro available, dose-dependent |
| Pharmacy | In-house licensed pharmacy — no third-party transfer |
| Provinces served | All 10, including Quebec and New Brunswick |
| Follow-up | 4-week titration cadence, included |
| Guarantee | 6-month money-back guarantee (terms apply) |
| Certification | LegitScript certified |
Pros and Cons
Pros
- ✓Generic semaglutide from around $149/month — among the lowest all-in pricing in Canada
- ✓The only major Canadian platform serving all ten provinces, including Quebec
- ✓In-house licensed pharmacy means faster fulfilment with no third-party transfer delay
- ✓Structured 4-week follow-up for dose titration, included in the consultation fee
- ✓LegitScript certified with named, credentialed clinical and pharmacy leadership
- ✓6-month money-back guarantee for patients who complete the program without meaningful loss
Cons
- ✗The $99 consultation fee is charged even if you are not approved for treatment
- ✗Does not directly bill private insurance — you get itemized receipts to submit yourself
- ✗Generic semaglutide only — no brand-name Ozempic or Wegovy option
- ✗No $0 assessment option, unlike Felix
How It Works
- 1.Complete the online health intake
Seven to ten minutes covering your weight history, conditions and current medications.
- 2.A licensed Canadian physician reviews it
Typically within 24 hours, with lab ordering through the partner lab network if needed.
- 3.Pay the $99 consultation
This covers the full clinical assessment, lab review, and first prescription if you are eligible. It is charged whether or not you are approved.
- 4.In-house pharmacy dispenses
Free tracked courier delivery in discreet packaging, dispatched directly rather than routed to a third-party pharmacy.
- 5.Titrate on a 4-week cadence
Structured follow-up for dose adjustment plus provider messaging, at no extra charge.
Pricing
| Consultation | $99 one-time |
|---|---|
| Generic semaglutide | From ~$149/month |
| Brand-name Ozempic | ~$200–$420/month depending on dose |
| Mounjaro (tirzepatide) | ~$350–$630/month depending on dose |
| Membership fee | None — ongoing support included in the $99 consult |
| Delivery | Free tracked courier, discreet packaging |
GLP-1 pricing scales with dose. Compare your expected maintenance dose, not the starting dose, when you price this against alternatives.
Who It's For
A good fit if…
- • Monthly cost is your deciding factor
- • You live in Quebec, where most national platforms do not operate
- • You want in-house pharmacy dispensing rather than a third-party transfer
- • You want a structured titration schedule rather than ad-hoc check-ins
Look elsewhere if…
- • You are unsure you will qualify and do not want to risk a $99 non-refundable consult
- • You specifically want brand-name Wegovy→ Felix carries the brand-name product.
- • You need a provider that bills private insurance directly
How It Compares
Rankings on this site weigh all-in cost in CAD, provincial coverage, clinical model and pharmacy model. Compare MyRocky against the alternatives before you commit:
Frequently Asked Questions
Is generic semaglutide the same as Ozempic?+
What happens if I am not approved?+
Does MyRocky serve Quebec?+
How does the money-back guarantee work?+
Which providers do you recommend in Canada?
Recommended Providers
Our editorial team’s top picks for this category.
Editorial Verdict
MyRocky is our top pick for Canadian GLP-1 weight loss, and the reasoning is not complicated: it is the cheapest credible program, it is the only major platform that serves Quebec, and it owns its pharmacy so refills do not stall in a transfer queue.
The generic semaglutide authorization changed the economics of this category in Canada, and MyRocky built the most complete program around it. At roughly $149 per month, it undercuts brand-name equivalents by a wide margin for the same active molecule.
The one real friction is the $99 consult being charged whether or not you are approved. If you are confident you meet the criteria — BMI 30+, or 27+ with a weight-related condition — that is a reasonable cost of entry. If you are genuinely unsure, get assessed free at Felix first and come back here for the medication economics.
Prescription notice
Provider independence
References and further reading
- Health Canada, Canada becomes the first G7 country to approve a generic semaglutide (Health Canada). First Canadian authorization of a generic semaglutide (2026).
- Health Canada, Canada approves first generic semaglutide for weight loss (Health Canada). First generic semaglutide authorized for chronic weight management.
- NEJM, STEP 1 trial of semaglutide for weight loss (New England Journal of Medicine). Landmark trial evidence for weight-loss effectiveness.
- Obesity Canada and CMAJ, 2025 pharmacotherapy guideline (CMAJ / Obesity Canada). Canadian obesity guideline on long-term weight-management medicine.
Compare Other Providers
Related Guides
Explore More Treatments
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.